All lobbying filings
Accendra Health Inc.
Accendra Health Inc. filed a Q3 report for Accendra Health Inc. on October 15, 2025.
Lobbying for Accendra Health Inc.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 15, 2025
Expenses
$190,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Virginia
Government bodies contacted
2
Lobbying activity
4
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
FY 2026 Appropriations.